Kimi Innovation Reports May 2026 Revenue of NT$0.50 Billion (YoY -28.2%)
Kimi Innovation (Stock Code: 4195) reported revenue of NT$499.6 million (approximately NT$0.50 billion) for May 2026, representing a 28.2% year-on-year decline. The result highlights short-term challenges in the biotech and healthcare sector.
📋 Article Processing Timeline
- 📰 Published: May 1, 2026 at 09:00
- 🔍 Collected: June 12, 2026 at 08:00 (1007h 0m after Published)
- 🤖 AI Analyzed: June 13, 2026 at 06:39 (22h 39m after Collected)
Company Code: 4195
Company Name: Kimi Innovation
Industry: Biotechnology and Healthcare
Data Month: May 2026
Monthly Revenue: NT$499,600 thousand (NT$0.50 billion)
Year-on-Year Change: -28.2%
Keywords: Monthly Revenue, Biotechnology and Healthcare Industry
Company Name: Kimi Innovation
Industry: Biotechnology and Healthcare
Data Month: May 2026
Monthly Revenue: NT$499,600 thousand (NT$0.50 billion)
Year-on-Year Change: -28.2%
Keywords: Monthly Revenue, Biotechnology and Healthcare Industry
FAQ
How did Kimi Innovation's May revenue change year-on-year?
Revenue dropped 28.2% YoY to NT$499.6 million, indicating short-term performance pressure.
What industry does Kimi Innovation operate in?
It operates in the biotechnology and healthcare sector, focusing on innovative medical solutions.
Why is this earnings report significant?
It serves as a benchmark for Taiwan's biotech firms and is closely watched by investors.